Why Kyverna Therapeutics Stock Is Sinking
Kyverna Therapeutics shares are falling Friday. The company released a presentation on KYV-101, its CD19 CAR T-cell candidate. Here's a look at the details:
Market Whales and Their Recent Bets on AMD Options
Investors with a lot of money to spend have taken a bearish stance on Advanced Micro Devices (NASDAQ:AMD).…
What the Options Market Tells Us About American Airlines Gr
Investors with a lot of money to spend have taken a bullish stance on American Airlines Gr (NASDAQ:AAL).…
Spotlight on Cleanspark: Analyzing the Surge in Options Activity
Financial giants have made a conspicuous bullish move on Cleanspark. Our analysis of options history for Cleanspark (NASDAQ:CLSK)…
Smart Money Is Betting Big In AVGO Options
Investors with a lot of money to spend have taken a bullish stance on Broadcom (NASDAQ:AVGO). And retail…
Market Whales and Their Recent Bets on PYPL Options
Whales with a lot of money to spend have taken a noticeably bearish stance on PayPal Holdings. Looking…
Analyst Ratings For Nexxen International
Throughout the last three months, 5 analysts have evaluated Nexxen International (NASDAQ:NEXN), offering a diverse set of opinions…
Beyond The Numbers: 10 Analysts Discuss Northern Oil & Gas Stock
During the last three months, 10 analysts shared their evaluations of Northern Oil & Gas (NYSE:NOG), revealing diverse…
Key Takeaways From Marriott Vacations Analyst Ratings
Analysts’ ratings for Marriott Vacations (NYSE:VAC) over the last quarter vary from bullish to bearish, as provided by…
Expert Outlook: Louisiana-Pacific Through The Eyes Of 5 Analysts
Analysts’ ratings for Louisiana-Pacific (NYSE:LPX) over the last quarter vary from bullish to bearish, as provided by 5…